Bayer

News

Kerendia pill bottle with tablets on surface

Bayer files finerenone in EU for heart failure

Bayer has filed its mineralocorticoid receptor antagonist finerenone as a treatment heart failure in the EU, but can it meet blockbuster sales hopes?

News

Bayer gains ground in two-fronted Parkinson's offensive

Bayer's cell therapy for Parkinson's disease is on the brink of a phase 3 trial, while its gene therapy has started phase 2 testing.

News

Official opening of Co.Lab Berlin site, ribbon cutting

Bayer opens Berlin incubator and welcomes first resident

Bayer's network of Co.Lab life sciences incubators has expanded once again with the official opening of a site in Berlin, its first in Europe

News

implantable hormone biosensor from Impli

Bayer partners medtech firm Impli on fertility R&D

Bayer has entered into an alliance with Impli, tapping into the start-up's implantable hormone-monitoring platform, which has potential in fertility treatment and other indications.

News

Lungs computer graphic in palm of a doctor's hand

Roivant's new 'vant' emerges to advance Bayer lung drug

Roivant's latest biotech company launch – Pulmovant – has made its debut with a plan to develop a respiratory drug licensed from Bayer in a deal worth up to $294 million.

News

WCLC: Bayer, Boehringer face off on HER2 cancers

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to t

Bayer files finerenone in EU for heart failure

Bayer gains ground in two-fronted Parkinson's offensive

Bayer opens Berlin incubator and welcomes first resident

Bayer partners medtech firm Impli on fertility R&D

Roivant's new 'vant' emerges to advance Bayer lung drug

WCLC: Bayer, Boehringer face off on HER2 cancers

DNA testing can help right racial imbalance in breast cancer

Using AI-driven synthetic personas to take your insights fur...

Bayer

Editor's Picks